Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no

Oscar C Marroquin1, Kevin E Kip, Suresh R Mulukutla

  • 1Cardiovascular Institute, Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA. marroquinoc@upmc.edu

American Heart Journal
|August 9, 2005
PubMed

Insights

Coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease (CAD) is not linked to inflammation or endothelial activation. These findings suggest inflammation may not drive this condition.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Inflammation Research

Background:

  • Coronary artery microvascular dysfunction (CMD) is common in women with chest pain and non-obstructive coronary artery disease (CAD).
  • Elevated inflammatory and endothelial activation markers are observed in patients with chest pain and non-obstructive CAD.
  • The link between inflammation, endothelial activation, and CMD remains unclear.

Purpose of the Study:

  • To investigate the association between markers of inflammation and endothelial cell activation and coronary flow reserve (CFR) in women with chest pain and non-obstructive CAD.
  • To determine if inflammation or endothelial activation plays a role in the pathophysiology of CMD in this patient group.

Main Methods:

  • Utilized data from the NHLBI WISE study, including 94 women with chest pain and non-obstructive CAD.
  • Assessed catheterization-based coronary flow reserve (CFR).
  • Measured serum levels of inflammatory markers (e.g., high-sensitivity C-reactive protein, IL-6, IL-18) and endothelial activation markers (e.g., soluble intracellular adhesion molecule-1).

Main Results:

  • Coronary flow reserve (CFR) showed no significant correlation with any measured inflammatory or endothelial activation markers.
  • Median levels of these markers did not differ between women with abnormal CFR and those with normal coronary microvascular function.
  • Multivariable analyses confirmed no association between inflammation/endothelial activation markers and CFR.

Conclusions:

  • Coronary microvascular dysfunction in women with chest pain and without obstructive CAD is not associated with systemic markers of inflammation or endothelial cell activation.
  • These findings suggest that inflammation and endothelial activation may not be key players in the development of CMD in this specific population.
Abstract

Related Concept Videos

Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...